β-cell function in individuals carrying the mitochondrial tRNA Leu (UUR) mutation

Pancreas

Volumn 34, Issue 1, 2007, Pages 133-137

  Salles, João Eduardo ^a   Kasamatsu, Teresa S ^a   Dib, Sérgio A ^a   Moisés, Regina S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cell function; C peptide; Mitochondrial DNA mutation

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; MITOCHONDRIAL DNA; SUSTACAL; TRANSFER RNA; UBIDECARENONE; UNCLASSIFIED DRUG; VINOCARD Q10;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; INSULIN RESPONSE; MALE; PANCREAS ISLET BETA CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADULT; C-PEPTIDE; DIABETES MELLITUS; DNA, MITOCHONDRIAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; PEDIGREE; POINT MUTATION; RNA, TRANSFER, LEU; UBIQUINONE; VITAMINS;

EID: 33846005866     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000246659.38375.4d     Document Type: Article

References (23)

1. LEU(UUR) gene in a large pedigree with maternally transmitted type II diabetes and deafness. Nat Genet. 1992;1:368-371.
2. Reardon W, Ross RJ, Sweeney MG, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet. 1993;341:1291-1292.
3. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med. 1994;30:962-968.
4. Leu (UUR) gene mutation. Diabetic Med. 1996;13:S98-S102.
5. Velho G, Byrne MM, Clèment C, et al. Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu (UUR) gene mutation. Diabetes. 1995;45:478-487.
6. Gebhart SS, Shoffner JM, Koontz D, et al. Insulin resistance associated with maternally inherited diabetes and deafness. Metabolism. 1996;45:526-531.
7. Alberti KGGM, Zimmet PZ, for the World Health Organization. Consultation, definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: WHO; 1999. Report of a WHO Consultation.
8. Cesarini PR, Mendon0a E, Fernandes V, et al. Prevalence of immunologic markers (Anti-GAD and Anti-IA-2) in first-degree relatives of patients with type I diabetes in greater area of São Paulo. Rev Assoc Med Bras. 2003;49:395-400.
9. Robert JJ, Deschamps I, Chevenne D, et al. Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type 1 diabetes in 220 juvenile first-degree relatives of diabetic patients. Diabetes. 1991;14:718-723.
10. Polonski KS. The b-cell and diabetes. Diabetes. 1995;45:705-717.
11. Gjessing HJ. C-peptide used in the estimation of islet b-cell function in diabetes. Dan Med Bull. 1992;39:438-452.
12. LEU(UUR) gene mutation. Diabetes Care. 2001;24:1253-1258.
13. Ganda OP, Srikanta S, Brink SJ, et al. Differential sensitivity to B-cell secretogogues in "early" type I diabetes mellitus. Diabetes. 1984;33:516-521.
14. Srikanta S, Ganda OP, Gleason RE, et al. Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose. Diabetes. 1984;33:717-720.
15. Brunzell JD, Robertson RP, Lerner RL, et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab. 1976;42:222-229.
16. Yousufzai SYK, Bradford MW, Shirago E, et al. Characterization of the adenine nucleotide translocase of pancreatic islet mitochondria. FEBS Lett. 1982;137:205-208.
17. Leu(UUR) gene causes severe mitochondrial dysfunction without a strong decrease in protein synthesis rate. J Biol Chem. 1999;274:29744-29748.
18. Yoneda M, Chomyn A, Martinuzzi A, et al. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proc Natl Acad Sci U S A. 1992;89:11164-11168.
19. Suzuki S, Kadowaki H, Atsumi Y, et al. A case of diabetic amyotrophy associated with 3243 mitochondrial tRNA(leu; UUR) mutation and successful therapy with Coenzyme Q10. Endocr J. 1995;42:141-145.
20. Suzuki S, Hinokio Y, Ohtomo M, et al. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia. 1998;41:584-588.
21. Leu (UUR) mutation: clinical features and coenzyme Q10 treatment. Mol Aspects Med. 1997;18(suppl 1):s181-s188.
22. Silvestre-Aillaud P, BenDahan D, Pasquis-Fluckinger V, et al. Could coenzyme Q10 and L-carnitine be a treatment for diabetes secondary to 3243 mutation of mtDNA? Diabetes Care. 1995;38:1485-1486.
23. Liou CW, Huang CH, Lin TK, et al. Correction of pancreatic B-cell dysfunction with coenzyme Q10 in a patient with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome and diabetes mellitus. Eur Neurol. 2000;43:54-56.